跳转至内容
Merck
CN

MAB8259

Anti-Influenza B Antibody, nucleoprotein, clone B2

clone B2, Chemicon®, from mouse

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
B2, monoclonal
Species reactivity:
human
Application:
IF
Citations:
2
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

mouse

antibody form

purified antibody

antibody product type

primary antibodies

clone

B2, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG1

shipped in

wet ice

Quality Level

Application

This Anti-Influenza B Antibody, nucleoprotein, clone B2 is validated for use in IF for the detection of Influenza B.

Physical form

Format: Purified

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

G Landgraf et al.
MethodsX, 8, 101442-101442 (2021-08-26)
We applied a one-step reverse transcriptase real-time PCR (rRT-PCR) analysis using TaqMan technique to evaluate the infectious titers of vaccine strains containing in trivalent live influenza vaccines (LAIVs). The cold-adapted reassortant influenza viruses A/H1N1 pdm09, A/H3N2, B/Yamagata and B/Victoria, included
Chung-Ming Yu et al.
Scientific reports, 10(1), 13318-13318 (2020-08-10)
Immunoassays based on sandwich immuno-complexes of capture and detection antibodies simultaneously binding to the target analytes have been powerful technologies in molecular analyses. Recent developments in single molecule detection technologies enable the detection limit of the sandwich immunoassays approaching femtomolar

商品

呼吸道传染病由于其传染性强、传播速度快且发病率高,已成为我国重点防治的一类疾病。目前呼吸道病原体检测方法主要分为血清特异性抗体检测、抗原检测、多重核酸检测以及微生物检测系统。其中,相比于抗体检测,抗原检测在感染病毒初期、出现症状后即可做出检测,适用于疾病的早期诊断,对患者的治疗具有重要指导意义。

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持